Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dodion

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cancer Treatment Reports|December 1, 1985
Doxorubicin and cisplatin excretion into human milkP C Egan, M E Costanza, P Dodion, et al.
Cancer Treatment Reports|May 1, 1986
Phase I study of triglycidylurazol given on a 5-day i.v. scheduleC Nicaise, M Rozencweig, N Crespeigne, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitroP Dodion, C Sanders, W Rombaut, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assayP Dodion, C Sanders, W Rombaut, et al.
Investigational New Drugs|January 1, 1986
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivativesD Bron, P Dodion, M Rozencweig, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1982
Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. scheduleP Dodion, M Rozencweig, C Nicaise, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugsP Dodion, D Bron, M A Mattelaer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Human pharmacokinetics of marcellomycinP Dodion, M Rozencweig, C Nicaise, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparative murine metabolism and disposition of class II anthracycline antibioticsP Dodion, M J Egorin, C E Riggs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data CenterJ B Vermorken, S Gundersen, M Clavel, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cancer Treatment Reports|December 1, 1985
Doxorubicin and cisplatin excretion into human milkP C Egan, M E Costanza, P Dodion, et al.
Cancer Treatment Reports|May 1, 1986
Phase I study of triglycidylurazol given on a 5-day i.v. scheduleC Nicaise, M Rozencweig, N Crespeigne, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitroP Dodion, C Sanders, W Rombaut, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1986
In vitro activity of menogaril and N-demethylmenogaril in a human tumor cloning assayP Dodion, C Sanders, W Rombaut, et al.
Investigational New Drugs|January 1, 1986
Quantitation of differential sensitivity of normal marrow myeloid progenitor cells to anthracene derivativesD Bron, P Dodion, M Rozencweig, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1982
Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. scheduleP Dodion, M Rozencweig, C Nicaise, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1987
Sensitivity of normal human bone marrow myeloid progenitor cells to anthracycline, cisplatin, anthracene and flavone acetic acid derivatives, and its relevance for the prediction of human plasma concentrations of anticancer drugsP Dodion, D Bron, M A Mattelaer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Human pharmacokinetics of marcellomycinP Dodion, M Rozencweig, C Nicaise, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1985
Comparative murine metabolism and disposition of class II anthracycline antibioticsP Dodion, M J Egorin, C E Riggs, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1993
Randomized phase II trial of iproplatin and carboplatin in advanced breast cancer. The EORTC Early Clinical Trials Group and the EORTC Data CenterJ B Vermorken, S Gundersen, M Clavel, et al.
Pageof 5